Superworth

Johnson & Johnson price to free cash flow JNJ

Market value divided by free cash flow over the last twelve months, since 2010.

Today, Oct 23, 2026
n/m
a quarter missing
10-year median
20.9×
10-year range
15.9× to 35.6×
Peer median
22.3×

Johnson & Johnson's price to free cash flow can't be checked today: its free cash flow for Q3 FY26, the quarter to Sep 27, 2026, is missing from our data, so the twelve months it rests on can't be added up.

On the days it had one over the last ten years, its median was 20.9×, from 15.9× in Mar 2020 to 35.6× in Jul 2026.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far28.6×25.1×35.6×
202525.5×16.5×26.0×
202416.8×16.8×24.8×
202324.0×22.5×31.1×
202226.0×19.3×26.4×
202120.1×18.7×24.0×
202022.6×15.9×23.2×
201919.5×17.5×20.4×
201818.5×17.7×21.4×
201720.3×19.8×24.4×
201622.9×17.9×23.6×
201519.0×18.5×20.7×
201420.1×17.6×20.8×
201319.5×15.8×22.1×
201215.3×14.4×16.2×
201115.0×10.6×15.1×
201010.9×10.1×11.7×

Against its peers

Companies in Drug Manufacturers - General nearest Johnson & Johnson's size, closest first, today.

CompanyPrice to free cash flow
JNJJohnson & Johnsonn/m
ABBVAbbVie27.7×
MRKMerck22.3×
LLYEli Lilly and65.9×
AMGNAmgen23.3×
GILDGilead Sciences14.9×
PFEPfizer15.6×
BMYBristol-Myers Squibb11.0×
Peer median22.3×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Johnson & Johnson

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.